AIHA is a heterogeneous autoimmune cytopenia with variable severity and significant morbidity. APS is defined by thrombosis and/or obstetric morbidity with persistent antiphospholipid antibodies (aPL).
Inclusion Criteria:
Exclusion Criteria:
asmaanady_1010@med.nvu.edu.eg01065161752
AIHA defined by: * Anemia plus hemolysis (↑LDH, ↑indirect bilirubin, ↓haptoglobin, reticulocytosis) and * Positive direct anti-globulin (Coombs) test , Drug induced hemolysis or other hereditary/acquired non immune hemolytic anemias.
Patients without hemolysis evidence
Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome
Immunopathology of Autoimmune Hemolytic Anemia
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
Data Registry of Auto Immune Hemolytic Anemia
Antiphospholipid Antibodies in Patients of Antiphospholipid Syndrome (APS) With Systemic Lupus Erythematosus (SLE).
Ankylosing Spondylitis and Antiphospholipid Antibodies
National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia
Auto-immunity and Pulmonary Arterial Hypertension